Following publication of this article [1], concerns were raised about the availability of the underlying data. This notice updates readers about the availability of the data with a corrected Data Availability statement.
The Data Availability statement is as follows:
The sequence and assembly data for each of the 40 gut microbiota samples is deposited at the CNGB Sequence Archive (https://db.cngb.org/cnsa/) under project accession number CNP0001174. The associated individual-level demographic data is deposited under accession number CNP0001169 (restricted data, for access requests visit https://db.cngb.org/data_access/).
Sample accession numbers are provided as Supporting Information on this notice (S1 File). Samples are grouped as follows:
Kazak, normal glucose tolerance (KNGT) = samples 1–10 (sample accessions CNS0254252-CNS0254261)
Kazak, diabetes mellitus type 2 (KDM2) = samples 11–20 (sample accessions CNS0254262—CNS0254271)
Uygur, normal glucose tolerance (UNGT) = samples 21–30 (sample accessions CNS0254272—CNS0254281)
Uygur, diabetes mellitus type 2 (UDM2) = samples 31–40 (sample accessions CNS0254282—CNS0254291)
Previously published studies on the same samples used 16S rDNA real time PCR to assess correlation between genus-level abundance of bacteria with physical and biochemical indicators in the same four groups [2]. Another previous study on the same samples reported physical and biochemical measurements as well as levels of indirect markers of bacterial exposure in the same four groups [3].
The following additional clarifications are provided regarding statistical analyses in [1]:
Sample size calculation
The sample size calculation uses the following experimental data from [2]:
By 16S rDNA real time PCR in genus level, the abundance of Veillonella spp and C. coccoides subgroups in Kazaks was obtained (KNGT VS KDM2: 2.10±0.20 VS 3.05±0.39; KNGT VS KDM2: 4.27±0.32 VS 4.80±0.19 Fig 1 and 2 of [2]). According to the following formula, we calculated the sample sizes of Kazaks as 4.47and 10.35, respectively.
The sample size calculation uses the following formula to compare two sample means:
Where numerator: σ is total variance; denominator: δ is mean difference between two groups. α = 0.05, β = 0.9, Zα = 1.96 and Zβ = 1.28
Considering the previously published prevalence of KDM2 (1.47%) [4] and the difficulties collecting KDM2 samples, the number of feces samples for Illumina sequencing was 10 (shown in table 1 and 2 [1]).
Data in Tables 1, 2 and 4 of [1] are reported as mean ± SD.
Supporting information
(DOCX)
References
- 1.Wang Y, Luo X, Mao X, Tao Y, Ran X, Zhao H, et al. (2017) Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks. PLoS ONE 12(3): e0172774. 10.1371/journal.pone.0172774 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Zhao H, Li L, Mao X, Zhang R, Xiong J, Wang Y. The relationship of Veillonella spp and C. coccoides subgroup levels in gut microbiota with type 2 diabetes mellitus in Uygurs and Kazaks of Xinjiang. Chinese Journal of Microecology. 2015;27(1):6–10. 10.13381/j.cnki.cjm.201501002 [DOI] [Google Scholar]
- 3.Zhang P, Li L, Xiong J, Zhao H, Mao X, Wang Y. The relationship of LBP, sCD14 levels with type 2 diabetes mellitus in Uygurs and Kazaks of Xinjiang . Chinese Journal of Microecology. 2014;26 (2):139–143. 10.13381/j.cnki.cjm.201402004 [DOI] [Google Scholar]
- 4.Tao Y, Mao X, Xie Z, Ran X, Liu X, Wang Y, et al. The Prevalence of Type 2 Diabetes and Hypertension in Uygur and Kazak Populations. Cardiovasc Toxicol. 2008; 8:155–159. 10.1007/s12012-008-9024-0 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
(DOCX)
